Labeler · US market

VIVUS LLC

VIVUS LLC is a US drug labeler with US FDA registrations covering 2 drug concepts (2 currently active) across 11 packages. It is currently the only active US supplier of 1 drug.

ACTIVE — US

openFDA · updated weekly

Labeler codes62541

Active drugs2

Registrations10 active / 10

Packages11

Sole supplier of1 drugs

Portfolio2 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease capsule, delayed release	rx	6	6	SUPPLYING
Phentermine And Topiramate capsule, extended release	rx	4	5	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Proteaserx

At a glance

TypeLabeler
Labeler codes62541
Filing names1
Drugs (active)2
Drugs (all time)2
US registrations10
Packages11

Recent events

Shortages, recalls, and registration changes across all filing names.

Jun 23, 2023
RECALLRecall (Class III): PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Camp…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.